| Study | Regimen | No. of patients | Age (years) | Duration# | Outcomes | Jadad | Treatment | Control |
| Cao et al. [12] | Tongluo Huaxian granules + PDN | PDN | 30/30 | 60.27/61.54 | 6 M | VC%, TLC% | 2 | Dong [13] | Kangxian Shufei granules + PDN | PDN | 33/33 | 59.11/57.7 | 3 M | DLCO%, PO2, FEV1%, FVC% | 1 | Fan et al. [14] | Kechuanting granules | PDN | 32/31 | 54.11/53.03 | 6 M | FEV1%, FEV1/FVC, | 1 | Tan and Li [15] | Shuizhi Tongluo capsule + PDN | PDN | 31/31 | 61.1/63.67 | 3 M | DLCO%, PO2 | 1 | Wang et al. [16] | Yangyin Yiqi Misture | PDN | 34/30 | 66.07/63.13 | 6 M | DLCO%, FEV1%, FVC%, | 2 | Weng and Ma [17] | Qingjin decoction + PDN | PDN | 42/42 | 52.66/53.33 | 6 M | PO2, FEV1%, | 2 | Chen et al. [18] | Huaxian Pogu formula + PDN | PDN | 25/25 | 63/65 | 3 M | VC%, DLCO%, TLC%, PO2 | 1 | Fan et al. [19] | Feixiantong decoction | NAC | 22/21 | 60.98/65.12 | 12 W | VC%, DLCO%, TLC% | 2 | Feng et al. [20] | Feixiankang granules + PDN | PDN | 30/30 | — | 6 M | DLCO%, PO2 | 1 | Gan et al. [21] | Huaxian decoction + PDN | PDN | 26/27 | 63.2/64.5 | 3 M | DLCO | 2 | Fan et al. [22] | Feitong oral liquid (high dose) | PDN | 73/65 | 59.01/58.27 | 3 M | DLCO%, TLC%, PO2, 6MWD | 5 | Fan et al. [22] | Feitong oral liquid (low dose) | PDN | 66/65 | 57.38/58.27 | 3 M | DLCO%, TLC%, PO2, 6MWD | 5 | Xu et al. [23] | Bufei Yishen Huoxue decoction + PDN | PDN | 35/35 | 52.32/51.51 | 12 W | DLCO%, PO2, FVC%, | 3 | Chen [24] | Danhong injection + PDN | PDN | 45/45 | 50.2/49.5 | 12 W | DLCO | 2 | Li et al. [25] | Feibitongfang | PDN | 23/22 | 59.97/64.59 | 12 W | VC%, TLC%, PO2 | 2 | Yan et al. [26] | Buyang Huanwu decoction + NAC | NAC | 60/60 | 63.5/63.4 | 6 M | DLCO%, PO2, FEV1% | 2 | Li et al. [27] | Yangyin Yifei Tongluo Wan | NAC | 34/30 | 58.23/59.98 | 3 M | VC%, DLCO%, TLC% | 2 | Liu et al. [28] | Xuefu Zhuyu capsule + NAC | NAC | 18/16 | — | 18 M | DLCO%, TLC%, PO2, FVC%, 6MWD | 2 | Song [29] | Xuefu Zhuyu decoction + PDN | PDN | 48/48 | 62.1/63.27 | 3 M | FEV1%, FVC%, SGRQ | 2 | Sun et al. [30] | Danhong injection + ED | ED | 35/35 | 48.2/50.8 | 12 W | DLCO, PO2 | 2 | Yan [31] | Danhong injection + PDN | PDN | 34/34 | 52.3/53.5 | 12 W | DLCO | 1 | Hu et al. [32] | Yiqi Huayu Tongluo decoction + PDN | PDN | 40/40 | 53.87/54.19 | 12 W | DLCO, PO2, SGRQ | 2 | Wang et al. [33] | Wenyang Huayu decoction + NAC | NAC | 43/37 | — | 3 M | VC%, DLCO%, TLC%, | 1 | Zhao and Wu [34] | Danhong Injection + NAC | NAC | 40/40 | 62.3/62.8 | 12 W | DLCO, PO2, FEV1/FVC | 1 | Han et al. [35] | Pingfeng Shengmai powder + PDN | PDN | 47/47 | 59.23/58.64 | 3 M | VC%, DLCO%, TLC%, PO2 | 1 | Hu [36] | Pingfeng Shengmai powder + PDN | PDN | 45/44 | 56.21/56.68 | 6 M | FEV1%, FVC%, 6MWD | 1 | Li et al. [37] | Peiyuan Huoxue decoction + PDN | PDN | 42/42 | 59.4/59.8 | 6 M | FEV1/FVC | 1 | Miao et al. [38] | Bushen Tongluo decoction | NAC | 28/27 | 62.36/65.68 | 12 W | VC%, DLCO%, 6MWD, SGRQ | 2 | Wang [39] | Xuefu Zhuyu decoction + PDN | PDN | 162/162 | 60.6/61.3 | 24 W | FVC% | 2 | Xie and Tong [40] | Yangyin Yiqi Misture + DXM | DXM | 45/45 | — | 3 M | FEV1/FVC, 6MWD, SGRQ | 2 | Xin and Feng [41] | Erjiaxiaozheng decoction | NAC | 25/24 | 65.68/65.88 | 6 M | 6MWD, SGRQ | 1 | Yuan et al. [42] | Bufei Yishen Huoxue Misture + DXM | DXM | 39/39 | 68.56/69.61 | 3 M | FEV1%, FEV1/FVC, 6MWD, SGRQ | 2 | Cui et.al. [43] | Fuzheng Tixie Souluo decoction | Placebo | 30/31 | 63.9/62.61 | 12 W | VC%, DLCO%, TLC%, FEV1%, FVC%, SGRQ | 4 | Deng and Wang [44] | Huangqi Taohong decoction + PDN | PDN | 59/59 | 64.06/63.21 | 3 M | DLCO%, PO2, FVC% | 2 | Feng and Sun [45] | Yifei Tongluo recipe + NAC | NAC | 31/31 | 61/62.3 | 6 M | DLCO, 6MWD | 2 | Fu and Lu [46] | Loubei Lengshu decoction | PDN | 50/50 | — | 3 M | DLCO%, TLC% | 2 | Gu [47] | Qishufeixian decoction + PFD | PFD | 30/30 | 62.3/63.8 | 6 M | FEV1%, FEV1/FVC, FVC%, SGRQ | 2 | Peng et al. [48] | Qigui recipe + PDN | PDN | 25/25 | 58.96/59.8 | 12 W | 6MWD, SGRQ | 3 | Wu [49] | Danhong injection + PDN | PDN | 30/30 | 61.56/61.8 | 12 W | DLCO, PO2 | 2 | Xi and Qin [50] | Huaxian Tongluo decoction + NAC | NAC | 30/30 | 65.11/64.28 | 3 M | VC%, DLCO%, TLC%, PO2, 6WMD, SGRQ | 2 | Zhao et al. [51] | Fuzheng Huaxian formula | NAC | 30/24 | 58/59 | 3 M | DLCO%, FVC%, 6MWD, SGRQ | 3 |
|
|